Polymyxin derivative (MicuRx Pharmaceuticals)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePolymyxin derivative (MicuRx Pharmaceuticals)
Drug Alias NameMRX-VIIIMRX-8PMX8
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell membrane permeability inhibitorsCell membrane structures modulatorsLipopolysaccharide (LPS) modulators
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMicuRx Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesMicuRx Pharmaceutical IncCARB-XShanghai MicuRx Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A